Editorial Commentary: Ancestry-Based Differences in Norovirus Susceptibility: Implications for Understanding Global Infection Patterns

Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults

(2014) D. I. Bernstein et al.   JOURNAL OF INFECTIOUS DISEASES

A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate—Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults

(2014) John J. Treanor et al.   JOURNAL OF INFECTIOUS DISEASES

Genotypic and Epidemiologic Trends of Norovirus Outbreaks in the United States, 2009 to 2013

(2013) E. Vega et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Predicting Susceptibility to Norovirus GII.4 by Use of a Challenge Model Involving Humans

(2012) R. Frenck et al.   JOURNAL OF INFECTIOUS DISEASES

Norovirus Vaccine against Experimental Human Norwalk Virus Illness

(2011) Robert L. Atmar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease

(2011) Carlos González-Juanatey et al.   ARTHRITIS RESEARCH & THERAPY

Genetic susceptibility to symptomatic norovirus infection in Nicaragua

(2009) Filemon Bucardo et al.   JOURNAL OF MEDICAL VIROLOGY

A Natural History of FUT2 Polymorphism in Humans

(2009) A. Ferrer-Admetlla et al.   MOLECULAR BIOLOGY AND EVOLUTION

The G428A Nonsense Mutation in FUT2 Provides Strong but Not Absolute Protection against Symptomatic GII.4 Norovirus Infection

(2009) Beatrice Carlsson et al.   PLoS One